Kvantify strengthens business development efforts, bringing in Dr. David Siebert as SVP, Global Head of Business Development

Copenhagen, April 15, 2026

Danish technology company Kvantify today announced strong new additions to its business development efforts, headlined by the news that Dr. David Siebert will join the company as SVP, Global Head of Business Development on April 15, 2026.

Delivering technology into the hands of actual users now

Kvantify has a mission to transform molecular discovery by coupling quantum and classical computing. Driven by a strong belief that “early beats perfect”, Kvantify delivers breakthrough hybrid quantum-classical technology into the hands of actual users now, not waiting for a future where quantum productivity will be widespread. The aim is to unlock solutions to real industrial challenges. And doing so requires strong business development efforts. Kvantify mainly works with innovators and early adopters that wish to be at the technological forefront.

“There is no established market for hybrid quantum-classical technology – yet, and therefore we build the market while we build the technology. This requires a highly skilled business development team, which is why we are very excited that David is joining and leading our efforts,” says Dr. Jörg Weiser, Executive Chairperson at Kvantify.

Strong additions to the business development team

With more than seven years of experience in international scientific business development across the TechBio and CRO (contract research organization) sectors, Dr. David Siebert joins Kvantify’s growing team, bringing a powerful blend of scientific and technical expertise coupled with commercial acumen.

David joins Kvantify from Syngene and has previously held roles at Schrödinger and Avantor, where he contributed to building and expanding strategic partnerships in global life sciences markets. He holds a PhD in Medicinal Chemistry from TU Wien and an MBA from Zürich International Business School.

“I am pleased to join Kvantify at such a pivotal moment for quantum-driven technologies and look forward to working with a talented team and visionary partners to help shape and drive transformative impact across the life sciences and beyond,” says Dr. David Siebert.

In addition, Glenn Jordan has recently joined Kvantify as VP of Business Development. He comes with 25+ years of experience working at the intersection between technology and life science / healthcare. His latest experience includes Genomics Ltd and IQVIA Inc.

“We are very happy to welcome David and Glenn to Kvantify. We are convinced that they will take our business development efforts to a whole new level, enabling our technology to solve complex problems in research organizations,” says Prof. Nikolaj Zinner, Co-founder and CSO at Kvantify.

Working with global business partners

Kvantify’s headquarters is ian Denmark, where there is a strong ecosystem around quantum technology, an impressive history and clear interest from politicians and investors. However, the solutions from Kvantify are not inherently Danish or Nordic – they are global. Therefore, Kvantify has now expanded the geographical coverage, using business partners to cover also the Asian markets.

Molecular Solutions Software Pvt ltd, run by Dr. Raghu Rangaswamy, former VP at Schrödinger India, is the partner covering markets from Middle East to South East Asia with a centre in India. TMK SOYAKU, run by former VP of Schrödinger Japan, Dr. Tomoko Satoh,is the partner covering Japan.